Lv3
240 积分 2025-11-24 加入
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
1天前
已完结
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma
3天前
已完结
Predictive biomarkers for molecularly targeted therapies and immunotherapies in breast cancer
5天前
已完结
Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer
20天前
已完结
Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes
22天前
已完结
Rozanolixizumab-noli
22天前
已关闭
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
27天前
已完结
Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
27天前
已完结
The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease
27天前
已完结
Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management
27天前
已完结
皖公网安备34019202002308
